These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15078152)
1. Phenotypic screening for pharmaceuticals using tissue constructs. Wakatsuki T; Fee JA; Elson EL Curr Pharm Biotechnol; 2004 Apr; 5(2):181-9. PubMed ID: 15078152 [TBL] [Abstract][Full Text] [Related]
2. Generating favorable growth factor and protease release profiles to enable extracellular matrix accumulation within an in vitro tissue engineering environment. Zhang X; Battiston KG; Labow RS; Simmons CA; Santerre JP Acta Biomater; 2017 May; 54():81-94. PubMed ID: 28242454 [TBL] [Abstract][Full Text] [Related]
3. Muscle on a chip: in vitro contractility assays for smooth and striated muscle. Grosberg A; Nesmith AP; Goss JA; Brigham MD; McCain ML; Parker KK J Pharmacol Toxicol Methods; 2012; 65(3):126-35. PubMed ID: 22521339 [TBL] [Abstract][Full Text] [Related]
4. Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering. van Geemen D; Driessen-Mol A; Grootzwagers LG; Soekhradj-Soechit RS; Riem Vis PW; Baaijens FP; Bouten CV Regen Med; 2012 Jan; 7(1):59-70. PubMed ID: 22168498 [TBL] [Abstract][Full Text] [Related]
5. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Peyton SR; Raub CB; Keschrumrus VP; Putnam AJ Biomaterials; 2006 Oct; 27(28):4881-93. PubMed ID: 16762407 [TBL] [Abstract][Full Text] [Related]
6. In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model. Ikeda K; Ito A; Imada R; Sato M; Kawabe Y; Kamihira M Sci Rep; 2017 Mar; 7():44570. PubMed ID: 28300163 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for modulators of cellular contractile force. Park CY; Zhou EH; Tambe D; Chen B; Lavoie T; Dowell M; Simeonov A; Maloney DJ; Marinkovic A; Tschumperlin DJ; Burger S; Frykenberg M; Butler JP; Stamer WD; Johnson M; Solway J; Fredberg JJ; Krishnan R Integr Biol (Camb); 2015 Oct; 7(10):1318-24. PubMed ID: 25953078 [TBL] [Abstract][Full Text] [Related]
8. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening. Kurokawa YK; George SC Adv Drug Deliv Rev; 2016 Jan; 96():225-33. PubMed ID: 26212156 [TBL] [Abstract][Full Text] [Related]
9. Functional evaluation of artificial skeletal muscle tissue constructs fabricated by a magnetic force-based tissue engineering technique. Yamamoto Y; Ito A; Fujita H; Nagamori E; Kawabe Y; Kamihira M Tissue Eng Part A; 2011 Jan; 17(1-2):107-14. PubMed ID: 20672996 [TBL] [Abstract][Full Text] [Related]
10. Engineering Cardiac Muscle Tissue: A Maturating Field of Research. Weinberger F; Mannhardt I; Eschenhagen T Circ Res; 2017 Apr; 120(9):1487-1500. PubMed ID: 28450366 [TBL] [Abstract][Full Text] [Related]
11. In-depth evaluation of commercially available human vascular smooth muscle cells phenotype: Implications for vascular tissue engineering. Timraz SBH; Farhat IAH; Alhussein G; Christoforou N; Teo JCM Exp Cell Res; 2016 May; 343(2):168-176. PubMed ID: 27079869 [TBL] [Abstract][Full Text] [Related]
13. Stromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue. Roberts MA; Tran D; Coulombe KL; Razumova M; Regnier M; Murry CE; Zheng Y Tissue Eng Part A; 2016 Apr; 22(7-8):633-44. PubMed ID: 26955856 [TBL] [Abstract][Full Text] [Related]
14. Stiffness of Aligned Fibers Regulates the Phenotypic Expression of Vascular Smooth Muscle Cells. Yi B; Shen Y; Tang H; Wang X; Li B; Zhang Y ACS Appl Mater Interfaces; 2019 Feb; 11(7):6867-6880. PubMed ID: 30676736 [TBL] [Abstract][Full Text] [Related]
15. Construction of functional soft tissues from premodulated smooth muscle cells using a bioreactor system. Cha JM; Park SN; Park GO; Kim JK; Suh H Artif Organs; 2006 Sep; 30(9):704-7. PubMed ID: 16934099 [TBL] [Abstract][Full Text] [Related]
16. Biologically active molecules that reduce polyglutamine aggregation and toxicity. Desai UA; Pallos J; Ma AA; Stockwell BR; Thompson LM; Marsh JL; Diamond MI Hum Mol Genet; 2006 Jul; 15(13):2114-24. PubMed ID: 16720620 [TBL] [Abstract][Full Text] [Related]
18. Force generation of different human cardiac valve interstitial cells: relevance to individual valve function and tissue engineering. Smith S; Taylor PM; Chester AH; Allen SP; Dreger SA; Eastwood M; Yacoub MH J Heart Valve Dis; 2007 Jul; 16(4):440-6. PubMed ID: 17702371 [TBL] [Abstract][Full Text] [Related]